BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 356 filers reported holding BIONTECH SE in Q4 2021. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $511,368 | -17.1% | 4,707 | -17.6% | 1.07% | +12.3% |
| Q2 2023 | $616,712 | -15.9% | 5,714 | -3.0% | 0.96% | -10.8% |
| Q1 2023 | $733,593 | -23.6% | 5,889 | -7.9% | 1.07% | -12.5% |
| Q4 2022 | $960,807 | -17.9% | 6,396 | -26.2% | 1.22% | +6.4% |
| Q3 2022 | $1,170,000 | -10.0% | 8,672 | -0.5% | 1.15% | -3.8% |
| Q2 2022 | $1,300,000 | -42.1% | 8,716 | -33.8% | 1.20% | -2.0% |
| Q1 2022 | $2,245,000 | -34.7% | 13,160 | -1.3% | 1.22% | +2.1% |
| Q4 2021 | $3,438,000 | -11.2% | 13,334 | -5.9% | 1.19% | -7.7% |
| Q3 2021 | $3,870,000 | -2.6% | 14,175 | -20.1% | 1.29% | -11.2% |
| Q2 2021 | $3,973,000 | +155.5% | 17,748 | +24.6% | 1.46% | +109.9% |
| Q1 2021 | $1,555,000 | +59.7% | 14,241 | +19.2% | 0.69% | +45.2% |
| Q4 2020 | $974,000 | – | 11,950 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |